SMC1A and myxosarcoma: Barretina et al. [12] reported 3.128-, 3.689-, 3.766- and 2.159-fold increased expression of SMC1A in pleomorphic liposarcoma, leiomyosarcoma, myxosarcoma and dedifferentiated liposarcoma, respectively (Table 1).